Skip to Content

Most Cited

  • Article
  • Open Access
232 Citations
16,659 Views
24 Pages

Neonatal Screening in Europe Revisited: An ISNS Perspective on the Current State and Developments Since 2010

  • J. Gerard Loeber,
  • Dimitris Platis,
  • Rolf H. Zetterström,
  • Shlomo Almashanu and ,
  • François Boemer,
  • James R. Bonham,
  • Patricia Borde,
  • Ian Brincat,
  • David Cheillan and
  • Peter C.J.I. Schielen
  • + 42 authors+ 37 authors

Neonatal screening (NBS) was initiated in Europe during the 1960s with the screening for phenylketonuria. The panel of screened disorders (“conditions”) then gradually expanded, with a boost in the late 1990s with the introduction of tandem mass spec...

  • Review
  • Open Access
226 Citations
78,101 Views
15 Pages

Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment

  • Baba P. D. Inusa,
  • Lewis L. Hsu,
  • Neeraj Kohli,
  • Anissa Patel and ,
  • Kilali Ominu-Evbota,
  • Kofi A. Anie and
  • Wale Atoyebi
  • + 2 authors+ 0 author

Sickle cell disease (SCD) is a monogenetic disorder due to a single base-pair point mutation in the β-globin gene resulting in the substitution of the amino acid valine for glutamic acid in the β-globin chain. Phenotypic variation in the clinical pre...

(This article belongs to the Special Issue Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies)
  • Review
  • Open Access
144 Citations
45,023 Views
184 Pages

Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020–2023)

  • Bradford L. Therrell,
  • Carmencita D. Padilla,
  • Gustavo J. C. Borrajo,
  • Issam Khneisser and ,
  • Peter C. J. I. Schielen,
  • Jennifer Knight-Madden,
  • Helen L. Malherbe and
  • Marika Kase
  • + 3 authors+ 0 author

Newborn bloodspot screening (NBS) began in the early 1960s based on the work of Dr. Robert “Bob” Guthrie in Buffalo, NY, USA. His development of a screening test for phenylketonuria on blood absorbed onto a special filter paper and transp...

  • Review
  • Open Access
126 Citations
13,288 Views
18 Pages

Newborn Screening for CF across the Globe—Where Is It Worthwhile?

  • Virginie Scotet,
  • Hector Gutierrez and
  • Philip M. Farrell

Newborn screening (NBS) for cystic fibrosis (CF) has been performed in many countries for as long as four decades and has transformed the routine method for diagnosing this genetic disease and improved the quality and quantity of life for people with...

(This article belongs to the Special Issue Newborn Screening for Cystic Fibrosis)
  • Review
  • Open Access
106 Citations
15,003 Views
11 Pages

Thalassemias: An Overview

  • Michael Angastiniotis and
  • Stephan Lobitz

Thalassemia syndromes are among the most serious and common genetic conditions. They are indigenous in a wide but specific geographical area. However, through migration they are spreading across regions not previously affected. Thalassemias are cause...

(This article belongs to the Special Issue Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies)
  • Article
  • Open Access
97 Citations
9,003 Views
5 Pages

Newborn Screening for X-Linked Adrenoleukodystrophy

  • Ann B. Moser,
  • Richard O. Jones,
  • Walter C. Hubbard,
  • Silvia Tortorelli and ,
  • Joseph J. Orsini,
  • Michele Caggana,
  • Beth H. Vogel and
  • Gerald V. Raymond
  • + 3 authors+ 0 author

Early diagnosis of males with X-linked adrenoleukodystrophy (X-ALD) is essential for preventing loss of life due to adrenal insufficiency and for timely therapy of the childhood cerebral form of X-ALD with hematopoietic cell transplantation. This art...

(This article belongs to the Special Issue Newborn Screening-Past, Present and Future)
  • Article
  • Open Access
92 Citations
10,372 Views
10 Pages

Dried blood spots (DBS) have been used in newborn screening (NBS) tests for over 50 years. The Newborn Screening Quality Assurance Program (NSQAP) at the Centers for Disease Control and Prevention (CDC) conducted studies to assess the individual impa...

  • Commentary
  • Open Access
80 Citations
17,138 Views
13 Pages

Newborn Screening by Genomic Sequencing: Opportunities and Challenges

  • David Bick,
  • Arzoo Ahmed,
  • Dasha Deen,
  • Alessandra Ferlini and ,
  • Nicolas Garnier,
  • Dalia Kasperaviciute,
  • Mathilde Leblond,
  • Amanda Pichini,
  • Augusto Rendon and
  • Richard H. Scott
  • + 7 authors+ 2 authors

Newborn screening for treatable disorders is one of the great public health success stories of the twentieth century worldwide. This commentary examines the potential use of a new technology, next generation sequencing, in newborn screening through t...

(This article belongs to the Special Issue Neonatal Screening in Europe: On the Brink of a New Era)
  • Review
  • Open Access
77 Citations
16,205 Views
17 Pages

Monitoring of patients with inherited metabolic disorders (IMDs) using dried blood spot (DBS) specimens has been routinely used since the inception of newborn screening (NBS) for phenylketonuria in the 1960s. The introduction of flow injection analys...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Review
  • Open Access
72 Citations
8,415 Views
30 Pages

Genomic advances have contributed to a proliferation of newborn screening (NBS) programs. Psychosocial consequences of NBS have been identified as risks to these public health initiatives. Following PRISMA guidelines, this systematic review synthesiz...

(This article belongs to the Special Issue Psychosocial Impact of Positive Newborn Screening)
  • Review
  • Open Access
71 Citations
15,768 Views
11 Pages

Newborn and Infant Hearing Screening Facing Globally Growing Numbers of People Suffering from Disabling Hearing Loss

  • Katrin Neumann,
  • Shelly Chadha,
  • George Tavartkiladze,
  • Xingkuan Bu and
  • Karl R. White

Recent prevalence estimates indicate that in 2015 almost half a billion people—about 6.8% of the world’s population—had disabling hearing loss and that prevalence numbers will further increase. The World Health Organization (WHO) cu...

(This article belongs to the Special Issue Newborn Hearing Screening)
  • Article
  • Open Access
68 Citations
9,312 Views
12 Pages

Reducing False-Positive Results in Newborn Screening Using Machine Learning

  • Gang Peng,
  • Yishuo Tang,
  • Tina M. Cowan,
  • Gregory M. Enns and ,
  • Hongyu Zhao and
  • Curt Scharfe
  • + 1 author+ 0 author

Newborn screening (NBS) for inborn metabolic disorders is a highly successful public health program that by design is accompanied by false-positive results. Here we trained a Random Forest machine learning classifier on screening data to improve pred...

(This article belongs to the Special Issue CLIR Applications for Newborn Screening)
  • Review
  • Open Access
67 Citations
9,856 Views
12 Pages

Newborn screening for lysosomal storage diseases (LSDs) is increasingly being considered as an option. The development of analytical screening methods, of second-tier methods, and of therapeutic possibilities, are paving the way for routine screening...

  • Article
  • Open Access
64 Citations
6,529 Views
12 Pages

Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy

  • Alberto B. Burlina,
  • Giulia Polo,
  • Laura Rubert,
  • Daniela Gueraldi and ,
  • Chiara Cazzorla,
  • Giovanni Duro,
  • Leonardo Salviati and
  • Alessandro P. Burlina
  • + 3 authors+ 0 author

The increasing availability of treatments and the importance of early intervention have stimulated interest in newborn screening for lysosomal storage diseases. Since 2015, 112,446 newborns in North Eastern Italy have been screened for four lysosomal...

  • Article
  • Open Access
61 Citations
10,119 Views
14 Pages

Expanded Newborn Screening in Italy Using Tandem Mass Spectrometry: Two Years of National Experience

  • Margherita Ruoppolo,
  • Sabrina Malvagia,
  • Sara Boenzi,
  • Carla Carducci and ,
  • Carlo Dionisi-Vici,
  • Francesca Teofoli,
  • Alberto Burlina,
  • Antonio Angeloni,
  • Tommaso Aronica and
  • Anna Paola Uccheddu
  • + 45 authors+ 40 authors

Newborn screening (NBS) for inborn errors of metabolism is one of the most advanced tools for secondary prevention in medicine, as it allows early diagnosis and prompt treatment initiation. The expanded newborn screening was introduced in Italy betwe...

(This article belongs to the Special Issue Tandem Mass Spectrometry in Newborn Screening)
  • Review
  • Open Access
60 Citations
18,282 Views
17 Pages

Newborn screening for 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, has been performed routinely in the United States and other countries for over 20 years. Screening provides the opportunity for early det...

(This article belongs to the Special Issue CAH Screening—Challenges and Opportunities)
  • Review
  • Open Access
60 Citations
11,133 Views
16 Pages

Development of Strategies to Decrease False Positive Results in Newborn Screening

  • Sabrina Malvagia,
  • Giulia Forni,
  • Daniela Ombrone and
  • Giancarlo la Marca

The expansion of national newborn screening (NBS) programmes has provided significant benefits in the diagnosis and early treatment of several rare, heritable conditions, preventing adverse health outcomes for most affected infants. New technological...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Article
  • Open Access
59 Citations
6,953 Views
15 Pages

All of the worldwide newborn screening (NBS) for lysosomal storage diseases (LSDs) is done by measurement of lysosomal enzymatic activities in dried blood spots (DBS). Substrates used for these assays are discussed. While the positive predictive valu...

(This article belongs to the Special Issue Newborn Screening for Lysosomal Storage Disorders)
  • Review
  • Open Access
57 Citations
8,616 Views
16 Pages

Newborn Screening for Pompe Disease

  • Takaaki Sawada,
  • Jun Kido and
  • Kimitoshi Nakamura

Glycogen storage disease type II (also known as Pompe disease (PD)) is an autosomal recessive disorder caused by defects in α-glucosidase (AαGlu), resulting in lysosomal glycogen accumulation in skeletal and heart muscles. Accumulation an...

(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
  • Article
  • Open Access
53 Citations
6,374 Views
14 Pages

Genetic results of uncertain clinical significance are being returned to parents following newborn screening, representing a paradigm change in how society considers health and illness. ‘Cystic Fibrosis screen positive, inconclusive diagnosis&r...

  • Review
  • Open Access
53 Citations
26,690 Views
10 Pages

Sickle cell disease (SCD) and other hemoglobinopathies are a major health concern with a high burden of disease worldwide. Since the implementation of newborn screening (NBS) for SCD and other hemoglobinopathies in several regions of the world, techn...

(This article belongs to the Special Issue Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies)
  • Review
  • Open Access
52 Citations
7,291 Views
12 Pages

All worldwide newborn screening (NBS) for lysosomal storage diseases (LSDs) is performed as a first-tier test by measurement of lysosomal enzymatic activities in dried blood spots (DBS). The currently two available methodologies used for measurement...

(This article belongs to the Special Issue Newborn Screening for Lysosomal Storage Disorders)
  • Article
  • Open Access
51 Citations
12,344 Views
12 Pages

Newborn Screening for Severe Combined Immunodeficiency in Taiwan

  • Yin-Hsiu Chien,
  • Hsin-Hui Yu,
  • Ni-Chung Lee,
  • Hui-Chen Ho and ,
  • Shu-Min Kao,
  • Meng-Yao Lu,
  • Tang-Her Jaing,
  • Wen-I Lee,
  • Kuei-Wen Chang and
  • Wuh-Liang Hwu
  • + 9 authors+ 4 authors

A study of newborn screening for severe combined immunodeficiency (SCID) by detecting the T-cell receptor excision circle (TRECs) copy number in dried blood spots (DBSs) collected from newborns 3 days of age began in 2010 in Taiwan, and SCID screenin...

(This article belongs to the Special Issue Newborn Screening for Primary Immunodeficiency Diseases – Past, Present and Future)
  • Article
  • Open Access
51 Citations
8,205 Views
12 Pages

The First Year Experience of Newborn Screening for Pompe Disease in California

  • Hao Tang,
  • Lisa Feuchtbaum,
  • Stanley Sciortino,
  • Jamie Matteson and ,
  • Deepika Mathur,
  • Tracey Bishop and
  • Richard S. Olney
  • + 2 authors+ 0 author

The California Department of Public Health started universal newborn screening for Pompe disease in August 2018 with a two-tier process including: (1) acid alpha-glucosidase (GAA) enzyme activity assay followed by, (2) GAA gene sequencing analysis. T...

(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
  • Article
  • Open Access
50 Citations
9,306 Views
25 Pages

Performance of Expanded Newborn Screening in Norway Supported by Post-Analytical Bioinformatics Tools and Rapid Second-Tier DNA Analyses

  • Trine Tangeraas,
  • Ingjerd Sæves,
  • Claus Klingenberg,
  • Jens Jørgensen and ,
  • Erle Kristensen,
  • Gunnþórunn Gunnarsdottir,
  • Eirik Vangsøy Hansen,
  • Janne Strand,
  • Emma Lundman and
  • Rolf D. Pettersen
  • + 28 authors+ 23 authors

In 2012, the Norwegian newborn screening program (NBS) was expanded (eNBS) from screening for two diseases to that for 23 diseases (20 inborn errors of metabolism, IEMs) and again in 2018, to include a total of 25 conditions (21 IEMs). Between 1 Marc...

(This article belongs to the Special Issue CLIR Applications for Newborn Screening)
  • Review
  • Open Access
48 Citations
11,044 Views
25 Pages

The Progress and Future of US Newborn Screening

  • Michael S. Watson,
  • Michele A. Lloyd-Puryear and
  • R. Rodney Howell

Progress in newborn screening (NBS) has been driven for 60 years by developments in science and technology, growing consumer advocacy, the actions of providers involved in the care of rare disease patients, and by federal and State government funding...

  • Article
  • Open Access
48 Citations
6,564 Views
13 Pages

Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up

  • Jamie Matteson,
  • Stanley Sciortino,
  • Lisa Feuchtbaum,
  • Tracey Bishop and ,
  • Richard S. Olney and
  • Hao Tang
  • + 1 author+ 0 author

X-linked adrenoleukodystrophy (ALD) is a recent addition to the Recommended Uniform Screening Panel, prompting many states to begin screening newborns for the disorder. We provide California’s experience with ALD newborn screening, highlighting the c...

(This article belongs to the Special Issue Newborn Screening and Follow-Up for X-ALD)
  • Review
  • Open Access
48 Citations
12,745 Views
10 Pages

Newborn Screening for SCD in the USA and Canada

  • Nura El-Haj and
  • Carolyn C. Hoppe

Sickle cell disease (SCD) encompasses a group of inherited red cell disorders characterized by an abnormal hemoglobin, Hb S. The most common forms of SCD in the United States and Canada are identified through universal newborn screening (NBS) program...

(This article belongs to the Special Issue Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies)
  • Review
  • Open Access
48 Citations
10,732 Views
14 Pages

Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm

  • Giancarlo la Marca,
  • Rachel. S. Carling,
  • Stuart. J. Moat,
  • Raquel Yahyaoui and ,
  • Enzo Ranieri,
  • James. R. Bonham and
  • Peter. C. J. I. Schielen
  • + 2 authors+ 0 author

In 1963, Robert Guthrie’s pioneering work developing a bacterial inhibition assay to measure phenylalanine in dried blood spots, provided the means for whole-population screening to detect phenylketonuria in the USA. In the following decades, N...

  • Review
  • Open Access
47 Citations
11,634 Views
15 Pages

Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories

  • Michael H. Gelb,
  • Khaja Basheeruddin,
  • Alberto Burlina,
  • Hsiao-Jan Chen and ,
  • Yin-Hsiu Chien,
  • George Dizikes,
  • Christine Dorley,
  • Roberto Giugliani,
  • Amy Hietala and
  • Dietrich Matern
  • + 21 authors+ 16 authors

Tandem mass spectrometry (MS/MS) is the most universal platform currently available for the analysis of enzymatic activities and biomarkers in dried blood spots (DBS) for applications in newborn screening (NBS). Among the MS/MS applications in NBS, t...

(This article belongs to the Special Issue Tandem Mass Spectrometry in Newborn Screening)
  • Article
  • Open Access
44 Citations
5,460 Views
10 Pages

Newborn screening (NBS) programs identify newborns at increased risk for genetic disorders, linking these newborns to timely intervention and potentially life-saving treatment. In the United States, the Health and Human Services (HHS) Advisory Commit...

(This article belongs to the Special Issue Newborn Screening for Spinal Muscular Atrophy)
  • Commentary
  • Open Access
44 Citations
8,138 Views
8 Pages

Newborn screening is a successful program in many developed countries. In India, the benefits of dried blood spot screening have been recognized and that screening is slowly gaining traction. There are significant issues standing in the way of univer...

(This article belongs to the Special Issue Newborn Screening: Promoting Quality to Optimise Benefit and Reduce Harm)
  • Article
  • Open Access
43 Citations
7,298 Views
17 Pages

Newborn Screening for Pompe Disease: Pennsylvania Experience

  • Can Ficicioglu,
  • Rebecca C. Ahrens-Nicklas,
  • Joshua Barch,
  • Sanmati R. Cuddapah and ,
  • Brenda S. DiBoscio,
  • James C. DiPerna,
  • Patricia L. Gordon,
  • Nadene Henderson,
  • Caitlin Menello and
  • Rui Xiao
  • + 7 authors+ 2 authors

Pennsylvania started newborn screening for Pompe disease in February 2016. Between February 2016 and December 2019, 531,139 newborns were screened. Alpha-Glucosidase (GAA) enzyme activity is measured by flow-injection tandem mass spectrometry (FIA/MS...

(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
  • Systematic Review
  • Open Access
42 Citations
9,882 Views
33 Pages

Systematic Review of Newborn Screening Programmes for Spinal Muscular Atrophy

  • Katy Cooper,
  • Gamze Nalbant,
  • Anthea Sutton,
  • Sue Harnan and ,
  • Praveen Thokala,
  • Jim Chilcott,
  • Alisdair McNeill and
  • Alice Bessey
  • + 3 authors+ 0 author

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder causing the degeneration of motor neurons in the spinal cord. Recent studies suggest greater effectiveness of treatment in the presymptomatic stage. This systematic review synthesises...

(This article belongs to the Special Issue Newborn Screening for SMA—State of the Art)
  • Article
  • Open Access
42 Citations
9,578 Views
9 Pages

Newborn Screening for Sickle Cell Disease in the Caribbean: An Update of the Present Situation and of the Disease Prevalence

  • Jennifer Knight-Madden,
  • Ketty Lee,
  • Gisèle Elana,
  • Narcisse Elenga and ,
  • Beatriz Marcheco-Teruel,
  • Ngozi Keshi,
  • Maryse Etienne-Julan,
  • Lesley King,
  • Monika Asnani and
  • Marie-Dominique Hardy-Dessources
  • + 6 authors+ 1 author

The region surrounding the Caribbean Sea is predominantly composed of island nations for its Eastern part and the American continental coast on its Western part. A large proportion of the population, particularly in the Caribbean islands, traces its...

(This article belongs to the Special Issue Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies)
  • Article
  • Open Access
41 Citations
7,460 Views
15 Pages

Australian Public Perspectives on Genomic Newborn Screening: Risks, Benefits, and Preferences for Implementation

  • Fiona Lynch,
  • Stephanie Best,
  • Clara Gaff,
  • Lilian Downie and ,
  • Alison D. Archibald,
  • Christopher Gyngell,
  • Ilias Goranitis,
  • Riccarda Peters,
  • Julian Savulescu and
  • Danya F. Vears
  • + 7 authors+ 2 authors

Recent dramatic reductions in the timeframe in which genomic sequencing can deliver results means its application in time-sensitive screening programs such as newborn screening (NBS) is becoming a reality. As genomic NBS (gNBS) programs are developed...

(This article belongs to the Special Issue Ethical and Psychosocial Aspects of Genomics in the Neonatal Period)
  • Systematic Review
  • Open Access
41 Citations
7,877 Views
34 Pages

Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy

  • Katy Cooper,
  • Gamze Nalbant,
  • Anthea Sutton,
  • Sue Harnan and ,
  • Praveen Thokala,
  • Jim Chilcott,
  • Alisdair McNeill and
  • Alice Bessey
  • + 3 authors+ 0 author

Spinal muscular atrophy (SMA) causes the degeneration of motor neurons in the spinal cord. Treatments including nusinersen, risdiplam, and onasemnogene abeparvovec have been shown to be effective in reducing symptoms, with recent studies suggesting g...

(This article belongs to the Special Issue Newborn Screening for SMA—State of the Art)
  • Review
  • Open Access
41 Citations
6,477 Views
17 Pages

Newborn Screening for Fabry Disease: Current Status of Knowledge

  • Vincenza Gragnaniello,
  • Alessandro P. Burlina,
  • Anna Commone,
  • Daniela Gueraldi and ,
  • Andrea Puma,
  • Elena Porcù,
  • Maria Stornaiuolo,
  • Chiara Cazzorla and
  • Alberto B. Burlina
  • + 4 authors+ 0 author

Fabry disease is an X-linked progressive lysosomal disorder, due to α-galactosidase A deficiency. Patients with a classic phenotype usually present in childhood as a multisystemic disease. Patients presenting with the later onset subtypes have...

  • Article
  • Open Access
40 Citations
6,584 Views
13 Pages

All newborn screening (NBS) for mucopolysaccharidosis-I (MPS-I) is carried out by the measurement of α-iduronidase (IDUA) enzymatic activity in dried blood spots (DBS). The majority of low enzyme results are due to pseudodeficiencies, and studi...

(This article belongs to the Special Issue Neonatal Screening for Mucopolysaccharidoses)
  • Review
  • Open Access
40 Citations
11,952 Views
14 Pages

Newborn screening is the largest genetic testing effort in the United States and is considered one of the ten great public health achievements during the first 10 years of the 21st century. For over 35 years, the Newborn Screening Quality Assurance P...

  • Review
  • Open Access
40 Citations
11,479 Views
12 Pages

Newborn Screening for Sickle Cell Disease in Europe

  • Yvonne Daniel,
  • Jacques Elion,
  • Bichr Allaf,
  • Catherine Badens and ,
  • Marelle J. Bouva,
  • Ian Brincat,
  • Elena Cela,
  • Cathy Coppinger,
  • Mariane de Montalembert and
  • Stephan Lobitz
  • + 11 authors+ 6 authors

The history of newborn screening (NBS) for sickle cell disease (SCD) in Europe goes back almost 40 years. However, most European countries have not established it to date. The European screening map is surprisingly heterogenous. The first countries t...

(This article belongs to the Special Issue Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies)
  • Systematic Review
  • Open Access
40 Citations
13,154 Views
14 Pages

Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?

  • Elena Schnabel-Besson,
  • Ulrike Mütze,
  • Nicola Dikow,
  • Friederike Hörster and ,
  • Marina A. Morath,
  • Karla Alex,
  • Heiko Brennenstuhl,
  • Sascha Settegast,
  • Jürgen G. Okun and
  • Stefan Kölker
  • + 7 authors+ 2 authors

Driven by technological innovations, newborn screening (NBS) panels have been expanded and the development of genomic NBS pilot programs is rapidly progressing. Decisions on disease selection for NBS are still based on the Wilson and Jungner (WJ) cri...

  • Review
  • Open Access
39 Citations
9,615 Views
11 Pages

Towards Achieving Equity and Innovation in Newborn Screening across Europe

  • Jaka Sikonja,
  • Urh Groselj,
  • Maurizio Scarpa,
  • Giancarlo la Marca and ,
  • David Cheillan,
  • Stefan Kölker,
  • Rolf H. Zetterström,
  • Viktor Kožich,
  • Yann Le Cam and
  • James R. Bonham
  • + 12 authors+ 7 authors

Although individual rare disorders are uncommon, it is estimated that, together, 6000+ known rare diseases affect more than 30 million people in Europe, and present a substantial public health burden. Together with the psychosocial burden on affected...

(This article belongs to the Special Issue Neonatal Screening in Europe: On the Brink of a New Era)
  • Review
  • Open Access
39 Citations
14,251 Views
10 Pages

In the US, the assay of T cell receptor excision circles (TRECs) in newborn dried blood spot specimens to detect severe combined immunodeficiency (SCID) was first piloted in 2008 in the state of Wisconsin. It has been rapidly adopted with 49 states a...

(This article belongs to the Special Issue Newborn Screening for Primary Immunodeficiency Diseases – Past, Present and Future)
  • Article
  • Open Access
39 Citations
10,256 Views
11 Pages

Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP® Neonatal Creatine Kinase-MM Kit in a US and Danish Population

  • Anne Timonen,
  • Michele Lloyd-Puryear,
  • David M. Hougaard,
  • Liisa Meriö and ,
  • Pauliina Mäkinen,
  • Ville Laitala,
  • Tuukka Pölönen,
  • Kristin Skogstrand,
  • Annie Kennedy and
  • Teemu Korpimäki
  • + 7 authors+ 2 authors

Duchenne muscular dystrophy (DMD/Duchenne) is a progressive X-linked disease and is the most common pediatric-onset form of muscular dystrophy, affecting approximately 1:5000 live male births. DNA testing for mutations in the dystrophin gene confirms...

(This article belongs to the Special Issue Selected Papers from 11th ISNS European Regional Meeting)
  • Article
  • Open Access
39 Citations
10,644 Views
11 Pages

Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA

  • Cristina Gutierrez-Mateo,
  • Anne Timonen,
  • Katja Vaahtera,
  • Markku Jaakkola and ,
  • David M Hougaard,
  • Jonas Bybjerg-Grauholm,
  • Marie Baekvad-Hansen,
  • Dea Adamsen,
  • Galina Filippov and
  • Rongcong Wu
  • + 8 authors+ 3 authors

Numerous studies have shown evidence supporting the benefits of universal newborn screening for primary immunodeficiencies (PID) and for Spinal Muscular Atrophy (SMA). We have developed a four-plex, real-time PCR assay to screen for Severe Combined I...

(This article belongs to the Special Issue Selected Papers from 11th ISNS European Regional Meeting)
  • Article
  • Open Access
39 Citations
9,437 Views
15 Pages

Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service

  • Julia C. van Campen,
  • Elizabeth S. A. Sollars,
  • Rebecca C. Thomas,
  • Clare M. Bartlett and ,
  • Antonio Milano,
  • Matthew D. Parker,
  • Jennifer Dawe,
  • Peter R. Winship,
  • Gerrard Peck and
  • Ann Dalton
  • + 9 authors+ 4 authors

Next generation DNA sequencing (NGS) has the potential to improve the diagnostic and prognostic utility of newborn screening programmes. This study assesses the feasibility of automating NGS on dried blood spot (DBS) DNA in a United Kingdom National...

  • Article
  • Open Access
39 Citations
6,415 Views
8 Pages

Newborn Screening for Pompe Disease in Illinois: Experience with 684,290 Infants

  • Barbara K. Burton,
  • Joel Charrow,
  • George E. Hoganson,
  • Julie Fleischer and ,
  • Dorothy K. Grange,
  • Stephen R. Braddock,
  • Lauren Hitchins,
  • Rachel Hickey,
  • Katherine M. Christensen and
  • Khaja Basheeruddin
  • + 9 authors+ 4 authors

Statewide newborn screening for Pompe disease began in Illinois in 2015. As of 30 September 2019, a total of 684,290 infants had been screened and 395 infants (0.06%) were screen positive. A total of 29 cases of Pompe disease were identified (3 infan...

(This article belongs to the Special Issue Newborn Screening for Pompe Disease)
  • Article
  • Open Access
39 Citations
10,257 Views
9 Pages

Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States

  • Phyllis W. Speiser,
  • Reeti Chawla,
  • Ming Chen,
  • Alicia Diaz-Thomas and ,
  • Courtney Finlayson,
  • Meilan M. Rutter,
  • David E. Sandberg,
  • Kim Shimy,
  • Rashida Talib and
  • + 8 authors+ 3 authors

Newborn screening for congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency is mandated throughout the US. Filter paper blood specimens are assayed for 17-hydroxyprogesterone (17OHP). Prematurity, low birth weight, or critical illn...

(This article belongs to the Special Issue CAH Screening—Challenges and Opportunities)
  • Article
  • Open Access
37 Citations
8,140 Views
12 Pages

Spinal Muscular Atrophy: Diagnosis, Incidence, and Newborn Screening in Japan

  • Tomokazu Kimizu,
  • Shinobu Ida,
  • Kentaro Okamoto,
  • Hiroyuki Awano and ,
  • Emma Tabe Eko Niba,
  • Yogik Onky Silvana Wijaya,
  • Shin Okazaki,
  • Hideki Shimomura,
  • Tomoko Lee and
  • Masakazu Shinohara
  • + 16 authors+ 11 authors

Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that causes degeneration of anterior horn cells in the human spinal cord and subsequent loss of motor neurons. The severe form of SMA is among the genetic diseases with the highest inf...

(This article belongs to the Collection Newborn Screening in Japan)
XFacebookLinkedIn
Int. J. Neonatal Screen. - ISSN 2409-515X